Catch up on the top radiology content of the past week.
|Articles|November 12, 1997
Kaiser taps ultrasound providers
Ultrasound vendors Acuson and Siemens Ultrasound are the latest recipients of contracts from HMO Kaiser Permanente. After naming Acuson to be its sole provider of radiology and vascular ultrasound systems (SCAN 9/3/97), Kaiser has also named Acuson its
Advertisement
Ultrasound vendors Acuson and Siemens Ultrasound are the latest recipients of contracts from HMO Kaiser Permanente. After naming Acuson to be its sole provider of radiology and vascular ultrasound systems (SCAN 9/3/97), Kaiser has also named Acuson its selected vendor for cardiac ultrasound systems in adult, pediatric, intraoperative, and stress echocardiography applications.
As part of the two-year, sole-source agreement, Kaiser will buy replacement and additional Sequoia C256 and Aspen echocardiography systems over the term of the contract. The agreement also includes two single-year extension options, according to Mountain View, CA-based Acuson. Kaiser's previous preferred vendor for cardiac ultrasound was Hewlett-Packard.
In another Kaiser contract, the HMO awarded Siemens Ultrasound a two-year agreement to be its sole provider of ob/gyn, emergency-room, and urology ultrasound scanners. Under the terms of the deal, Kaiser will purchase multiple Sonoline Prima systems. The contract is valued at $1 million per year, according to the Issaquah, WA-based firm.
Advertisement
Related to this article
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
In a recent interview, Stamatia Destounis, MD, FACR, shared her perspective on recent changes to the BI-RADS system, offering insights on contrast-enhanced mammography, reporting changes for breast MRI and ultrasound, and the importance of auditing for BI-RADS category 3 assessments.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Emerging Research Insights and New Advances in Neuroradiology
2
MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?
3
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
4
Current Perspectives on Integrating AI into Radiology
5